(AMWL) American Well - Ratings and Ratios

American Well Corporation (NYSE:AMWL), a leader in telehealth solutions, provides a cloud-based platform called Converge, enabling healthcare providers, payers, and innovators to deliver hybrid care. Their services include virtual primary care, chronic condition management, and post-discharge follow-ups. Amwell enhances clinical settings with Carepoint devices, transforming equipment into digital access points. They offer professional services for implementation and engagement, selling through various channels to providers, payers, government, and education sectors. Founded in 2006, Amwell is based in Boston and known for integrating telehealth into existing healthcare systems.

3-Month Forecast: AMWLs stock is undervalued with a low P/B (0.64) and P/S (0.74), though the negative RoE (-68.29%) reflects significant losses. Technically, the stock is below SMA 20 and SMA 50 but above SMA 200, with moderate volatility (ATR 0.79). Expect short-term volatility with potential stabilization as the company addresses profitability. Investors should monitor for signs of revenue growth and cost management.